Early recurrence of adult type ovarian granulosa cell tumor in sigmoid colon: a case report

Document Type : Case report

Authors

1 Associate Professor, Department of Obstetrics and Gynecology, Supporting the family and the youth of the population research core, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran.

2 Fellowship of Gynecology Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran.

Abstract

Introduction: Ovarian granulosa cell tumors (GCT) include 2-3% of ovarian cancers. This study reported a rare case of granulosa at the age of 35 with early recurrence in sigmoid colon.
Case presentation: A 35-year-old female, Noli Gravid, with a history of primary infertility and a complaint of abdominal pain referred to Ghaem Hospital in Mashhad, Iran. With the diagnosis of ovarian mass, she underwent laparotomy. The intraoperative frozen examination was for an ovarian granulosa tumor. Right salpingo-opheretomy with surgical staging and endometrial curettage were done. The final pathology was adult-type granulosa tumor and other samples were normal. Three cycles of chemotherapy were performed. After 18 months of non-follow up, she returned with a complaint of abdominal pain. An 8 cm mass on the left side of the pelvis was reported. She was candidate for surgery. There was a mass attached to the mesenter of the sigmoid colon which was resected and sent for frozen. Frozen analysis reported the recurrence of the granulosa tumor. A total hysterectomy with a left salpingo-oophorectomy was performed. Then she underwent pelvic radiotherapy.
Conclusion: Recurrence is the main cause of patients' death. Due to late recurrence, patients should be trained to pay attention to the symptoms of recurrence in order to cooperate in long-term follow-up for early diagnosis of recurrence band treatment. Considering the rare cases of extra-pelvic and extra-genital recurrences, there is a need for new treatment strategies to be carried out in the form of clinical trials to improve the quality of life of patients and prevent frequent recurrences leading to their mortality.

Keywords

Main Subjects


  1. Pilsworth JA, Cochrane DR, Neilson SJ, Moussavi BH, Lai D, Munzur AD, et al. Adult‐type granulosa cell tumor of the ovary: a FOXL2‐centric disease. The Journal of Pathology: Clinical Research 2021; 7(3):243-52.
  2. Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P, et al. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2018; 29:iv1-8.
  3. Dridi M, Chraiet N, Batti R, Ayadi M, Mokrani A, Meddeb K, et al. Granulosa cell tumor of the ovary: a retrospective study of 31 cases and a review of the literature. International Journal of Surgical Oncology 2018; 2018.
  4. Bryk S, Pukkala E, Martinsen JI, Unkila‐Kallio L, Tryggvadottir L, Sparen P, et al. Incidence and occupational variation of ovarian granulosa cell tumours in Finland, Iceland, Norway and Sweden during 1953–2012: a longitudinal cohort study. BJOG: An International Journal of Obstetrics & Gynaecology 2017; 124(1):143-9.
  5. East N, Alobaid A, Goffin F, Ouallouche K, Gauthier P. Granulosa cell tumour: a recurrence 40 years after initial diagnosis. Journal of Obstetrics and Gynaecology Canada 2005; 27(4):363-4.
  6. Bryk S, Katuwal S, Haltia UM, Tapper J, Tapanainen JS, Pukkala E. Parity, menopausal hormone therapy, and risk of ovarian granulosa cell tumor–a population-based case-control study. Gynecologic oncology 2021; 163(3):593-7.
  7. Wang D, Xiang Y, Wu M, Shen K, Yang J, Huang H, et al. Clinicopathological characteristics and prognosis of adult ovarian granulosa cell tumor: a single-institution experience in China. OncoTargets and therapy 2018: 1315-22.
  8. Zhao D, Zhang Y, Ou Z, Zhang R, Zheng S, Li B. Characteristics and treatment results of recurrence in adult-type granulosa cell tumor of ovary. Journal of ovarian research 2020; 13:1-10.
  9. Meisel JL, Hyman DM, Jotwani A, Zhou Q, Abu-Rustum NR, Iasonos A, et al. The role of systemic chemotherapy in the management of granulosa cell tumors. Gynecologic oncology 2015; 136(3):505-11.
  10. Wang D, Xiang Y, Wu M, Shen K, Yang J, Huang H, et al. Is adjuvant chemotherapy beneficial for patients with FIGO stage IC adult granulosa cell tumor of the ovary?. Journal of Ovarian Research 2018; 11:1-7.
  11. Karalok A, Ureyen I, Tasci T, Basaran D, Turkmen O, Boran N, et al. Maximum surgical effort is warranted for recurrent adult granulosa cell tumors of ovary. Tumori Journal 2016; 102(4):404-8.
  12. Yasukawa M, Matsuo K, Matsuzaki S, Dainty LA, Sugarbaker PH. Management of recurrent granulosa cell tumor of the ovary: Contemporary literature review and a proposal of hyperthermic intraperitoneal chemotherapy as novel therapeutic option. Journal of Obstetrics and Gynaecology Research 2021; 47(1):44-51.
  13. Lappöhn RE, Burger HG, Bouma J, Bangah M, Krans M, De Bruijn HW. Inhibin as a marker for granulosa-cell tumors. New England Journal of Medicine 1989; 321(12):790-3.
  14. Burger HG. What do inhibin measurements tell a clinician today?. Annals of medicine 1992; 24(6):419-21.
  15. Chang HL, Pahlavan N, Halpern EF, MacLaughlin DT. Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology. Gynecologic oncology 2009; 114(1):57-60.
  16. Crisponi L, Uda M, Deiana M, Loi A, Nagaraja R, Chiappe F, et al. FOXL2 inactivation by a translocation 171 kb away: analysis of 500 kb of chromosome 3 for candidate long-range regulatory sequences. Genomics 2004; 83(5):757-64.
  17. Thomakos N, Biliatis I, Koutroumpa I, Sotiropoulou M, Bamias A, Liontos M, et al. Prognostic factors for recurrence in early stage adult granulosa cell tumor of the ovary. Archives of Gynecology and Obstetrics 2016; 294:1031-6.
  18. Plett H, Ricciardi E, Vacaru V, Ramspott JP, Colombo N, Sehouli J, et al. Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence. International Journal of Gynecologic Cancer 2023; 33(5).
  19. Gu Y, Wang D, Jia C, Chen L, Cang W, Wan X, et al. Clinical characteristics and oncological outcomes of recurrent adult granulosa cell tumor of ovary: A retrospective study of seventy patients. Acta Obstetricia et Gynecologica Scandinavica 2023; 102(6):782-90.